<DOC>
	<DOCNO>NCT02756338</DOCNO>
	<brief_summary>The purpose study evaluate safety feasibility perform BioMonitor 2 insertion procedure office setting .</brief_summary>
	<brief_title>BioMonitor 2 In-Office Setting Insertion Safety Feasibility Evaluation With Device Functionality Assessment</brief_title>
	<detailed_description />
	<criteria>Indicated continuous monitoring insertable cardiac monitor Willing implanted office set local anesthetic available Able understand nature study provide inform consent Able willing complete routine followup visit study site expect 90day followup Able willing use CardioMessengerÂ® capable communicate BioMonitor 2 Age great equal 18 year At time insertion , follow preprocedure criterion must meet subject undergo insertion : Most recent INR value ( within 7 day ) less 3.5 currently take warfarin Absence infection history infection within last 30 day Compromised immune system high risk develop infection Abnormal thoracic anatomy scar tissue implant site may adversely impact insertion procedure Enrolled investigational cardiac device trial Currently indicate implanted pacemaker , ICD device , hemodynamic monitoring system Currently implant ICM ILR Life expectancy le 6 month Patients report pregnancy time enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>